118 related articles for article (PubMed ID: 16778112)
21. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
22. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.
Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J
Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19).
Spaeth N; Wyss MT; Pahnke J; Biollaz G; Trachsel E; Drandarov K; Treyer V; Weber B; Neri D; Buck A
Nucl Med Biol; 2006 Jul; 33(5):661-6. PubMed ID: 16843841
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
[TBL] [Abstract][Full Text] [Related]
26. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
27. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
28. Complexation and biodistribution study of 111In and 90Y complexes of bifunctional phosphinic acid analogs of H4dota.
Försterová M; Petrík M; Láznicková A; Láznícek M; Hermann P; Lukes I; Melichar F
Appl Radiat Isot; 2009 Jan; 67(1):21-9. PubMed ID: 18951809
[TBL] [Abstract][Full Text] [Related]
29. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
30. Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.
Reardon DA; Zalutsky MR; Bigner DD
Expert Rev Anticancer Ther; 2007 May; 7(5):675-87. PubMed ID: 17492931
[TBL] [Abstract][Full Text] [Related]
31. [Current experience of stereotaxic irradiations in the treatment of hemispheric gliomas (author's transl)].
Szikla G; Betti O; Szenthe L; Schlienger M
Neurochirurgie; 1981; 27(5):295-8. PubMed ID: 7038523
[TBL] [Abstract][Full Text] [Related]
32. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
33. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with
Majkowska-Pilip A; Koźmiński P; Wawrzynowska A; Budlewski T; Kostkiewicz B; Gniazdowska E
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301182
[TBL] [Abstract][Full Text] [Related]
34.
Królicki L; Kunikowska J; Bruchertseifer F; Koziara H; Królicki B; Jakuciński M; Pawlak D; Rola R; Morgenstern A; Rosiak E; Merlo A
Semin Nucl Med; 2020 Mar; 50(2):141-151. PubMed ID: 32172799
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Results of Targeted Low-Grade Glioma Treatment with
Cordier D; Merlo A
Cancer Biother Radiopharm; 2019 Aug; 34(6):413-416. PubMed ID: 30844298
[TBL] [Abstract][Full Text] [Related]
36. Comparing monoclonal antibodies and small peptidic hormones for local targeting of malignant gliomas.
Merlo A; Mueller-Brand J; Maecke HR
Acta Neurochir Suppl; 2003; 88():83-91. PubMed ID: 14531566
[TBL] [Abstract][Full Text] [Related]
37. Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models.
Israel I; Blass G; Reiners C; Samnick S
Nucl Med Biol; 2011 May; 38(4):451-60. PubMed ID: 21531282
[TBL] [Abstract][Full Text] [Related]
38. Locoregional Treatment of Glioblastoma With Targeted α Therapy: [ 213 Bi]Bi-DOTA-Substance P Versus [ 225 Ac]Ac-DOTA-Substance P-Analysis of Influence Parameters.
Królicki L; Kunikowska J; Bruchertseifer F; Kuliński R; Pawlak D; Koziara H; Rola R; Morgenstern A; Merlo A
Clin Nucl Med; 2023 May; 48(5):387-392. PubMed ID: 36854309
[TBL] [Abstract][Full Text] [Related]
39.
Lyczko M; Pruszynski M; Majkowska-Pilip A; Lyczko K; Was B; Meczynska-Wielgosz S; Kruszewski M; Szkliniarz K; Jastrzebski J; Stolarz A; Bilewicz A
Nucl Med Biol; 2017 Oct; 53():1-8. PubMed ID: 28683361
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and properties of triacetic acid.
WITTER RF; STOTZ E
J Biol Chem; 1948 Nov; 176(2):485-92. PubMed ID: 18889905
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
